Fig. 4From: The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathwayImmunofluorescence analysis of Nrf2 and Keap1 in ACC-83 treated with MG132(40µM) for 12 h. Scale bars: 40 μm. A B Nrf2 and Keap1 punctate dots were visualized by fluorescence microscopy and representative images were presentedBack to article page